GLUE MONTE ROSA THERAPEUTICS INC
2026Q1 · CUSIP 61225M102 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
189
Δ holders QoQ
+28
Breadth percentile
Top 11%
Whale holders
99
Δ whales
+16
Inst. holding value
$1.4B
New positions
51
Closed positions
23
Price momentum (1Q)
-1.9%
Put / Call
3/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 11% | — | — |
| 2025Q4 | Top 16% | -1.9% | — |
| 2022Q3 | Top 10% | -25.5% | -38.8% |
Options Sentiment
Put holders
3
QoQ: 0
Call holders
3
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.48
EPS YoY
-1333.3%
Revenue (TTM)
$0.0B
Revenue YoY
-73.1%
Net margin
-302.7%
ROE
-24.9%
Debt ratio
29.1%
FCF (TTM)
-$20M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.